相似文献
1
Transposon-based screens for cancer gene discovery in mouse models.
Semin Cancer Biol. 2010 Aug;20(4):261-8. doi: 10.1016/j.semcancer.2010.05.003. Epub 2010 May 15.
2
Identification of cancer driver genes using Sleeping Beauty transposon mutagenesis.
Cancer Sci. 2021 Jun;112(6):2089-2096. doi: 10.1111/cas.14901. Epub 2021 May 1.
3
Identification of Sleeping Beauty transposon insertions in solid tumors using linker-mediated PCR.
J Vis Exp. 2013 Feb 1(72):e50156. doi: 10.3791/50156.
4
Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies.
Semin Cell Dev Biol. 2014 Mar;27:86-95. doi: 10.1016/j.semcdb.2014.01.006. Epub 2014 Jan 24.
5
Cancer Gene Discovery Utilizing Sleeping Beauty Transposon Mutagenesis.
Methods Mol Biol. 2019;1907:161-170. doi: 10.1007/978-1-4939-8967-6_13.
6
Sleeping beauty: a novel cancer gene discovery tool.
Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R75-9. doi: 10.1093/hmg/ddl061.
7
Transposon-mediated mutagenesis of somatic cells in the mouse for cancer gene identification.
Methods. 2009 Nov;49(3):282-6. doi: 10.1016/j.ymeth.2009.07.002. Epub 2009 Jul 14.
8
PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice.
Science. 2010 Nov 19;330(6007):1104-7. doi: 10.1126/science.1193004. Epub 2010 Oct 14.
9
Sleeping Beauty transposon insertional mutagenesis based mouse models for cancer gene discovery.
Curr Opin Genet Dev. 2015 Feb;30:66-72. doi: 10.1016/j.gde.2015.04.007. Epub 2015 Jun 4.
10
Ex Vivo Transposon-Mediated Genetic Screens for Cancer Gene Discovery.
Methods Mol Biol. 2019;1907:145-157. doi: 10.1007/978-1-4939-8967-6_12.
引用本文的文献
1
Exploring transposable elements: new horizons in cancer diagnostics and therapeutics.
Mob DNA. 2025 Jul 12;16(1):28. doi: 10.1186/s13100-025-00366-9.
2
Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.
Nat Commun. 2023 Jul 18;14(1):4313. doi: 10.1038/s41467-023-39935-y.
3
Transmicron: accurate prediction of insertion probabilities improves detection of cancer driver genes from transposon mutagenesis screens.
Nucleic Acids Res. 2023 Feb 28;51(4):e21. doi: 10.1093/nar/gkac1215.
4
The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells.
EMBO Mol Med. 2021 Apr 9;13(4):e13162. doi: 10.15252/emmm.202013162. Epub 2021 Mar 10.
5
CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets.
Genome Biol. 2020 Aug 19;21(1):204. doi: 10.1186/s13059-020-02118-9.
6
A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.
Genes (Basel). 2019 Aug 13;10(8):614. doi: 10.3390/genes10080614.
7
A simplified transposon mutagenesis method to perform phenotypic forward genetic screens in cultured cells.
BMC Genomics. 2019 Jun 17;20(1):497. doi: 10.1186/s12864-019-5888-6.
8
Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice.
Sci Rep. 2019 Apr 2;9(1):5488. doi: 10.1038/s41598-019-41805-x.
9
Development of a Mouse Model of Prostate Cancer Using the Sleeping Beauty Transposon and Electroporation.
Molecules. 2018 Jun 5;23(6):1360. doi: 10.3390/molecules23061360.
10
SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.
PLoS Genet. 2017 Mar 8;13(3):e1006650. doi: 10.1371/journal.pgen.1006650. eCollection 2017 Mar.
本文引用的文献
1
Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach.
Cancer Res. 2010 Feb 1;70(3):883-95. doi: 10.1158/0008-5472.CAN-09-1737. Epub 2010 Jan 26.
2
Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality.
Cancer Res. 2009 Nov 1;69(21):8429-37. doi: 10.1158/0008-5472.CAN-09-1760. Epub 2009 Oct 20.
3
A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice.
Cancer Res. 2009 Oct 15;69(20):8150-6. doi: 10.1158/0008-5472.CAN-09-1135. Epub 2009 Oct 6.
4
Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras.
Nature. 2009 Sep 17;461(7262):411-4. doi: 10.1038/nature08279. Epub 2009 Sep 2.
5
High-throughput insertional mutagenesis screens in mice to identify oncogenic networks.
Nat Rev Cancer. 2009 Jun;9(6):389-99. doi: 10.1038/nrc2647.
6
Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.
Nat Genet. 2009 Jun;41(6):753-61. doi: 10.1038/ng.343. Epub 2009 May 3.
7
Chromosomal mobilization and reintegration of Sleeping Beauty and PiggyBac transposons.
Genesis. 2009 Jun;47(6):404-8. doi: 10.1002/dvg.20508.
8
The NemaGENETAG initiative: large scale transposon insertion gene-tagging in Caenorhabditis elegans.
Genetica. 2009 Sep;137(1):39-46. doi: 10.1007/s10709-009-9361-3. Epub 2009 Apr 3.
9
Parallel progression of primary tumours and metastases.
Nat Rev Cancer. 2009 Apr;9(4):302-12. doi: 10.1038/nrc2627.
10
A transposon-based genetic screen in mice identifies genes altered in colorectal cancer.
Science. 2009 Mar 27;323(5922):1747-50. doi: 10.1126/science.1163040. Epub 2009 Feb 26.
Zotero 插件